Medical - Instruments & Supplies
Compare Stocks
4 / 10Stock Comparison
OSUR vs HOLX vs BDX vs QDEL
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Medical - Instruments & Supplies
Medical - Instruments & Supplies
OSUR vs HOLX vs BDX vs QDEL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $225M | $16.97B | $55.53B | $733M |
| Revenue (TTM) | $85M | $4.13B | $21.36B | $2.66B |
| Net Income (TTM) | $-53M | $544M | $1.14B | $-1.21B |
| Gross Margin | 38.8% | 52.8% | 46.5% | 56.6% |
| Operating Margin | -58.6% | 17.5% | 10.6% | -37.0% |
| Forward P/E | — | 17.2x | 12.3x | 6.4x |
| Total Debt | $13M | $2.63B | $19.18B | $2.80B |
| Cash & Equiv. | $199K | $1.96B | $851M | $170M |
OSUR vs HOLX vs BDX vs QDEL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| OraSure Technologie… (OSUR) | 100 | 21.5 | -78.5% |
| Hologic, Inc. (HOLX) | 100 | 142.6 | +42.6% |
| Becton, Dickinson a… (BDX) | 100 | 103.0 | +3.0% |
| QuidelOrtho Corpora… (QDEL) | 100 | 6.2 | -93.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OSUR vs HOLX vs BDX vs QDEL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OSUR is the clearest fit if your priority is income & stability.
- Dividend streak 2 yrs, beta 1.45
HOLX carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 124.3% 10Y total return vs BDX's 80.2%
- Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
- Beta 0.41, current ratio 3.75x
- 13.2% margin vs OSUR's -61.9%
BDX is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
- 8.2% revenue growth vs OSUR's -38.1%
- 2.7% yield; 1-year raise streak; the other 3 pay no meaningful dividend
- +51.8% vs QDEL's -58.3%
QDEL is the clearest fit if your priority is value.
- Lower P/E (6.4x vs 12.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.2% revenue growth vs OSUR's -38.1% | |
| Value | Lower P/E (6.4x vs 12.3x) | |
| Quality / Margins | 13.2% margin vs OSUR's -61.9% | |
| Stability / Safety | Beta 0.41 vs QDEL's 2.59, lower leverage | |
| Dividends | 2.7% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +51.8% vs QDEL's -58.3% | |
| Efficiency (ROA) | 6.1% ROA vs QDEL's -20.7%, ROIC 9.4% vs -13.6% |
OSUR vs HOLX vs BDX vs QDEL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OSUR vs HOLX vs BDX vs QDEL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOLX leads in 3 of 6 categories
QDEL leads 1 • BDX leads 1 • OSUR leads 1
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOLX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BDX is the larger business by revenue, generating $21.4B annually — 251.0x OSUR's $85M. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to OSUR's -61.9%. On growth, HOLX holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $85M | $4.1B | $21.4B | $2.7B |
| EBITDAEarnings before interest/tax | -$45M | $974M | $4.2B | -$649M |
| Net IncomeAfter-tax profit | -$53M | $544M | $1.1B | -$1.2B |
| Free Cash FlowCash after capex | -$33M | $1000M | $3.1B | -$75M |
| Gross MarginGross profit ÷ Revenue | +38.8% | +52.8% | +46.5% | +56.6% |
| Operating MarginEBIT ÷ Revenue | -58.6% | +17.5% | +10.6% | -37.0% |
| Net MarginNet income ÷ Revenue | -61.9% | +13.2% | +5.3% | -45.6% |
| FCF MarginFCF ÷ Revenue | -38.9% | +24.2% | +14.7% | -2.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -99.9% | +2.5% | -10.6% | -10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -52.4% | -9.2% | -2.0% | -6.1% |
Valuation Metrics
QDEL leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 26.3x trailing earnings, BDX trades at a 14% valuation discount to HOLX's 30.5x P/E. On an enterprise value basis, BDX's 14.7x EV/EBITDA is more attractive than HOLX's 17.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $225M | $17.0B | $55.5B | $733M |
| Enterprise ValueMkt cap + debt − cash | $238M | $17.6B | $73.9B | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | -3.33x | 30.53x | 26.29x | -0.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.21x | 12.27x | 6.45x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.59x | — |
| EV / EBITDAEnterprise value multiple | — | 17.39x | 14.65x | — |
| Price / SalesMarket cap ÷ Revenue | 1.96x | 4.14x | 2.54x | 0.27x |
| Price / BookPrice ÷ Book value/share | 0.67x | 3.43x | 1.73x | 0.38x |
| Price / FCFMarket cap ÷ FCF | — | 18.44x | 20.80x | — |
Profitability & Efficiency
HOLX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-56 for QDEL. OSUR carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to QDEL's 1.46x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs OSUR's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -15.1% | +11.0% | +4.5% | -56.3% |
| ROA (TTM)Return on assets | -12.8% | +6.1% | +2.1% | -20.7% |
| ROICReturn on invested capital | -20.0% | +9.4% | +4.3% | -13.6% |
| ROCEReturn on capital employed | -16.8% | +8.8% | +5.4% | -18.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.04x | 0.52x | 0.76x | 1.46x |
| Net DebtTotal debt minus cash | $13M | $667M | $18.3B | $2.6B |
| Cash & Equiv.Liquid assets | $199,278 | $2.0B | $851M | $170M |
| Total DebtShort + long-term debt | $13M | $2.6B | $19.2B | $2.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 8.00x | 4.09x | -5.18x |
Total Returns (Dividends Reinvested)
BDX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BDX five years ago would be worth $11,693 today (with dividends reinvested), compared to $891 for QDEL. Over the past 12 months, BDX leads with a +51.8% total return vs QDEL's -58.3%. The 3-year compound annual growth rate (CAGR) favors BDX at 1.6% vs QDEL's -50.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +31.5% | +1.9% | +0.7% | -62.6% |
| 1-Year ReturnPast 12 months | +12.2% | +37.1% | +51.8% | -58.3% |
| 3-Year ReturnCumulative with dividends | -55.2% | -8.5% | +5.0% | -87.8% |
| 5-Year ReturnCumulative with dividends | -68.3% | +15.8% | +16.9% | -91.1% |
| 10-Year ReturnCumulative with dividends | -53.1% | +124.3% | +80.2% | -34.9% |
| CAGR (3Y)Annualised 3-year return | -23.5% | -2.9% | +1.6% | -50.4% |
Risk & Volatility
HOLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than QDEL's 2.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs QDEL's 27.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.45x | 0.41x | 0.66x | 2.59x |
| 52-Week HighHighest price in past year | $3.82 | $76.04 | $205.52 | $38.99 |
| 52-Week LowLowest price in past year | $2.08 | $52.81 | $100.31 | $10.22 |
| % of 52W HighCurrent price vs 52-week peak | +81.9% | +100.0% | +74.6% | +27.6% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 69.1 | 32.2 | 35.2 |
| Avg Volume (50D)Average daily shares traded | 473K | 10.0M | 2.5M | 2.2M |
Analyst Outlook
OSUR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: OSUR as "Hold", HOLX as "Hold", BDX as "Buy", QDEL as "Buy". Consensus price targets imply 57.8% upside for QDEL (target: $17) vs 3.9% for HOLX (target: $79). BDX is the only dividend payer here at 2.72% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $4.00 | $79.00 | $172.85 | $17.00 |
| # AnalystsCovering analysts | 13 | 42 | 33 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.7% | — |
| Dividend StreakConsecutive years of raises | 2 | — | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — | $4.17 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +6.7% | +4.4% | +1.8% | 0.0% |
HOLX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). QDEL leads in 1 (Valuation Metrics).
OSUR vs HOLX vs BDX vs QDEL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OSUR or HOLX or BDX or QDEL a better buy right now?
For growth investors, Becton, Dickinson and Company (BDX) is the stronger pick with 8.
2% revenue growth year-over-year, versus -38. 1% for OraSure Technologies, Inc. (OSUR). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate Becton, Dickinson and Company (BDX) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OSUR or HOLX or BDX or QDEL?
On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.
3x versus Hologic, Inc. at 30. 5x. On forward P/E, QuidelOrtho Corporation is actually cheaper at 6. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OSUR or HOLX or BDX or QDEL?
Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +16.
9%, compared to -91. 1% for QuidelOrtho Corporation (QDEL). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus OSUR's -53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OSUR or HOLX or BDX or QDEL?
By beta (market sensitivity over 5 years), Hologic, Inc.
(HOLX) is the lower-risk stock at 0. 41β versus QuidelOrtho Corporation's 2. 59β — meaning QDEL is approximately 530% more volatile than HOLX relative to the S&P 500. On balance sheet safety, OraSure Technologies, Inc. (OSUR) carries a lower debt/equity ratio of 4% versus 146% for QuidelOrtho Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — OSUR or HOLX or BDX or QDEL?
By revenue growth (latest reported year), Becton, Dickinson and Company (BDX) is pulling ahead at 8.
2% versus -38. 1% for OraSure Technologies, Inc. (OSUR). On earnings-per-share growth, the picture is similar: QuidelOrtho Corporation grew EPS 45. 4% year-over-year, compared to -261. 5% for OraSure Technologies, Inc.. Over a 3-year CAGR, BDX leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OSUR or HOLX or BDX or QDEL?
Hologic, Inc.
(HOLX) is the more profitable company, earning 13. 8% net margin versus -59. 8% for OraSure Technologies, Inc. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus -59. 2% for OSUR. At the gross margin level — before operating expenses — HOLX leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OSUR or HOLX or BDX or QDEL more undervalued right now?
On forward earnings alone, QuidelOrtho Corporation (QDEL) trades at 6.
4x forward P/E versus 17. 2x for Hologic, Inc. — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for QDEL: 57. 8% to $17. 00.
08Which pays a better dividend — OSUR or HOLX or BDX or QDEL?
In this comparison, BDX (2.
7% yield) pays a dividend. OSUR, HOLX, QDEL do not pay a meaningful dividend and should not be held primarily for income.
09Is OSUR or HOLX or BDX or QDEL better for a retirement portfolio?
For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
66), 2. 7% yield). QuidelOrtho Corporation (QDEL) carries a higher beta of 2. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BDX: +80. 2%, QDEL: -34. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OSUR and HOLX and BDX and QDEL?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
BDX pays a dividend while OSUR, HOLX, QDEL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.